Process Optimization for Purifying Two Batches of Tirzepatide API with Different Purity Levels Application 1: Crude Peptide (purity: 74.95%) Purification Process: Primary Purification Packing Material: Xtimate C8, 10m, 120 Results : After primary purification, purity reached 92.44%, with a recovery rate of 75%
For instance, Novo Nordisk plans to initiate late-stage clinical trials of its experimental obesity drug, amycretin, in both injectable and oral forms during the first quarter of 2026
This blog post will examine the complex interaction between genetics and birth control to explain the growing need for personalized contraceptive methods
Research-grade tirzepatide peptide products sold for laboratory applications are intended for research use only and are not approved for human consumption
That tiny difference, just 0.4 percentage points, tells an important story